Free Trial

Lam Research (LRCX) Stock Forecast & Price Target

Lam Research logo
$83.25 +1.75 (+2.15%)
As of 01/22/2025 04:00 PM Eastern

Lam Research - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
14

Based on 22 Wall Street analysts who have issued ratings for Lam Research in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 8 have given a hold rating, and 14 have given a buy rating for LRCX.

Consensus Price Target

$95.77
15.03% Upside
According to the 22 analysts' twelve-month price targets for Lam Research, the average price target is $95.77. The highest price target for LRCX is $120.00, while the lowest price target for LRCX is $75.00. The average price target represents a forecasted upside of 15.03% from the current price of $83.25.
Get the Latest News and Ratings for LRCX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lam Research and its competitors.

Sign Up

LRCX Analyst Ratings Over Time

TypeCurrent Forecast
1/24/24 to 1/23/25
1 Month Ago
12/25/23 to 12/24/24
3 Months Ago
10/26/23 to 10/25/24
1 Year Ago
1/24/23 to 1/24/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
13 Buy rating(s)
14 Buy rating(s)
14 Buy rating(s)
Hold
8 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$95.77$97.24$97.03$71.05
Forecasted Upside15.03% Upside31.70% Upside24.91% Upside-16.23% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

LRCX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LRCX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lam Research Stock vs. The Competition

TypeLam ResearchComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.64
2.68
2.52
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside15.03% Upside54.07% Upside11.77% Upside
News Sentiment Rating
Positive News

See Recent LRCX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/17/2025Barclays
3 of 5 stars
Tom O'Malley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$90.00 ➝ $75.00-5.33%
1/17/2025KeyCorp
3 of 5 stars
Steve Barger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$95.00 ➝ $95.00+19.92%
1/15/2025Wolfe Research
3 of 5 stars
Chris Caso
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
1/13/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joseph Quatrochi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$83.00 ➝ $82.00+11.13%
1/10/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Vijay Rakesh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$95.00 ➝ $90.00+20.66%
1/10/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Toshiya Hari
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$96.00 ➝ $85.00+13.14%
12/5/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$76.00 ➝ $78.00+0.13%
11/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$95.00 ➝ $85.00+18.76%
10/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ramel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
10/24/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$100.00 ➝ $100.00+32.35%
10/24/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$105.00 ➝ $100.00+32.45%
10/24/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$100.00 ➝ $100.00+37.25%
10/23/2024B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Ellis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$132.50 ➝ $105.00+44.13%
9/16/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$99.00 ➝ $89.30+18.88%
9/12/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$125.00 ➝ $115.00+53.89%
8/1/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$110.00 ➝ $95.00+15.45%
8/1/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $105.00+13.98%
6/7/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$95.00 ➝ $106.00+9.93%
5/13/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy ➝ Buy$98.00 ➝ $110.00+20.16%
4/25/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$90.00 ➝ $95.00+5.04%
4/25/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$88.00 ➝ $85.00-3.94%
4/16/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$120.00+26.83%
11/22/2023Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$80.00+13.09%
4/20/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$53.00 ➝ $55.50+6.92%
3/1/2023KGI Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:12 AM ET.


Should I Buy Lam Research Stock? LRCX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, January 12, 2025. Please send any questions or comments about these Lam Research pros and cons to contact@marketbeat.com.

Lam Research
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Lam Research Co.:

  • Lam Research Co. has recently reported strong quarterly earnings, with earnings per share (EPS) of $0.86, surpassing analysts' expectations of $0.81. This indicates robust financial performance and effective management.
  • The stock is currently trading at $76.59, which may present a buying opportunity for investors looking for potential growth as analysts have set a consensus price target of $97.24.
  • Several analysts have maintained a "buy" rating on Lam Research Co., reflecting confidence in the company's future performance and growth potential in the semiconductor industry.
  • The company has a solid market capitalization of approximately $98.55 billion, indicating its significant presence and stability in the market.
  • Lam Research Co. has a healthy dividend yield of 1.18%, providing investors with a return on their investment through regular dividend payments, which can be particularly appealing in a volatile market.

Lam Research
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Lam Research Co. for these reasons:

  • Wells Fargo & Company recently lowered its price target for Lam Research Co. from $85.00 to $83.00, which may indicate a more cautious outlook on the stock's short-term performance.
  • The stock has experienced significant volatility, with a one-year high of $113.00 and a low of $68.87, suggesting potential risks for investors who may be sensitive to price fluctuations.
  • Analysts have noted a decrease in revenue compared to the previous year, with a reported revenue of $4.17 billion, which, while above expectations, reflects a decline from last year's figures.
  • The company has a relatively high price-to-earnings (P/E) ratio of 24.75, which may suggest that the stock is overvalued compared to its earnings, potentially deterring value-focused investors.
  • Recent downgrades from various research firms, including a shift from "buy" to "hold" ratings, may signal a lack of confidence in the stock's immediate growth prospects.

LRCX Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Lam Research is $95.77, with a high forecast of $120.00 and a low forecast of $75.00.

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lam Research in the last twelve months. There are currently 8 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" LRCX shares.

According to analysts, Lam Research's stock has a predicted upside of 15.03% based on their 12-month stock forecasts.

Over the previous 90 days, Lam Research's stock had 1 upgrade and 1 downgrade by analysts.

Lam Research has been rated by research analysts at Barclays, KeyCorp, Mizuho, Morgan Stanley, Sanford C. Bernstein, The Goldman Sachs Group, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Lam Research less than other "computer and technology" companies. The consensus rating score for Lam Research is 2.64 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how LRCX compares to other companies.


This page (NASDAQ:LRCX) was last updated on 1/23/2025 by MarketBeat.com Staff
From Our Partners